Date:02-May-2024  Time: 5:13 PM
 
 
        
Zydus Lifesciences Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales2225.102050.002869.902437.30
Other Income106.80534.5082.40251.20
Total Income2478.102693.803038.102830.50
Total Expenditure 1672.201509.901814.702010.60
Operating Profit805.901183.901223.40819.90
Interest103.9090.9089.7085.00
Gross Profit702.001093.001133.70734.90
Depreciation127.70124.90121.20119.90
Tax118.80171.60236.40129.60
Deferred Tax5.10-8.50-4.80-5.30
Reported Profit After Tax450.40805.00780.90490.70
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com